Insulin Nation – FDA Gives Diabetes Treatments Low Priority

Even though health officials readily admit that diabetes is an urgent public health problem, a new diabetes medicine or device usually finds itself in ninth position on the FDA docket for a pre-market clearance. To understand why requires an understanding of the history of the FDA, and its limitations.

Read more

Posted in Other News